Shanghai Junshi Biosciences Co., Ltd. (HKG:1877)

HKG:1877 Revenue

Shanghai Junshi Biosciences had revenue of 500.59M CNY in the quarter ending March 31, 2025, with 31.46% growth. This brings the company's revenue in the last twelve months to 2.07B, up 27.02% year-over-year. In the year 2024, Shanghai Junshi Biosciences had annual revenue of 1.95B with 29.67% growth.

• Revenue (ttm): 2.07B CNY
• Revenue Growth: +27.02%
• P/S Ratio: 12.15
• Revenue / Employee: 802.21K CNY
• Employees: 2,578
• Market Cap: 26.95B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.95B	445.77M	29.67%
Dec 31, 2023	1.50B	49.06M	3.38%
Dec 31, 2022	1.45B	-2.57B	-63.89%
Dec 31, 2021	4.02B	2.43B	152.36%
Dec 31, 2020	1.59B	819.81M	105.77%